WOLRAB, Denise, Robert JIRASKO, Eva CIFKOVA, Marcus HORING, Ding MEI, Michaela CHOCHOLOUSKOVA, Ondrej PETERKA, Jakub IDKOWIAK, Tereza HRNCIAROVA, Ladislav KUCHAR, Robert AHRENDS, Radana BRUMAROVA, David FRIEDECKY, Gabriel VIVO-TRUYOLS, Pavel SKRHA, Jan SKRHA, Radek KUCERA, Bohuslav MELICHAR, Gerhard LIEBISCH, Ralph BURKHARDT, Markus R. WENK, Amaury CAZENAVE-GASSIOT, Petr KARASEK, Ivo NOVOTNY, Kristína GREPLOVÁ, Roman HRSTKA and Michal HOLCAPEK. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nature Communications. BERLIN: Nature Publishing Group, 2022, vol. 13, No 1, p. 1-16. ISSN 2041-1723. Available from: https://dx.doi.org/10.1038/s41467-021-27765-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Lipidomic profiling of human serum enables detection of pancreatic cancer
Authors WOLRAB, Denise, Robert JIRASKO (203 Czech Republic), Eva CIFKOVA (203 Czech Republic), Marcus HORING, Ding MEI, Michaela CHOCHOLOUSKOVA (203 Czech Republic), Ondrej PETERKA (203 Czech Republic), Jakub IDKOWIAK (203 Czech Republic), Tereza HRNCIAROVA (203 Czech Republic), Ladislav KUCHAR (203 Czech Republic), Robert AHRENDS, Radana BRUMAROVA (203 Czech Republic), David FRIEDECKY (203 Czech Republic), Gabriel VIVO-TRUYOLS, Pavel SKRHA (203 Czech Republic), Jan SKRHA (203 Czech Republic), Radek KUCERA (203 Czech Republic), Bohuslav MELICHAR (203 Czech Republic), Gerhard LIEBISCH, Ralph BURKHARDT, Markus R. WENK, Amaury CAZENAVE-GASSIOT, Petr KARASEK (203 Czech Republic), Ivo NOVOTNY (203 Czech Republic), Kristína GREPLOVÁ (203 Czech Republic, belonging to the institution), Roman HRSTKA (203 Czech Republic) and Michal HOLCAPEK (203 Czech Republic, guarantor).
Edition Nature Communications, BERLIN, Nature Publishing Group, 2022, 2041-1723.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 16.600
RIV identification code RIV/00216224:14110/22:00127203
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1038/s41467-021-27765-9
UT WoS 000797924100001
Keywords in English lipidomic profiling; human serum; pancreatic cancer
Tags 14110811, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 19/2/2024 11:26.
Abstract
Pancreatic cancer has the worst prognosis among all cancers. Cancer screening of body fluids may improve the survival time prognosis of patients, who are often diagnosed too late at an incurable stage. Several studies report the dysregulation of lipid metabolism in tumor cells, suggesting that changes in the blood lipidome may accompany tumor growth. Here we show that the comprehensive mass spectrometric determination of a wide range of serum lipids reveals statistically significant differences between pancreatic cancer patients and healthy controls, as visualized by multivariate data analysis. Three phases of biomarker discovery research (discovery, qualification, and verification) are applied for 830 samples in total, which shows the dysregulation of some very long chain sphingomyelins, ceramides, and (lyso) phosphatidylcholines. The sensitivity and specificity to diagnose pancreatic cancer are over 90%, which outperforms CA 19-9, especially at an early stage, and is comparable to established diagnostic imaging methods. Furthermore, selected lipid species indicate a potential as prognostic biomarkers.
Links
90125, large research infrastructuresName: BBMRI-CZ III
PrintDisplayed: 18/7/2024 17:34